Sunday, November 17, 2013

Use of compounded therapies ‘worth the headache,’ speaker says

Bennie H. Jeng, MD, said these agents have been “a mainstay for many conditions in our field,” in glaucoma and cornea care, and in anti-VEGF and intravitreal injections.
Compounding allows physicians to customize dosages, provide allergen-free and preservative-free medications, and provide formulations not normally available, he said.
Antibiotics can be fortified, cyclosporine can be formulated in other percentages, and retinoic acid can be adapted for ophthalmic use, Jeng said.

No comments: